(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide

C26H30ClF4N3O4S — CID 163944078

IUPAC(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide
SMILESCC(C)(C)OC[NH+]([O-])[C@H]1CSc2cc(F)c(C(=O)NCCCC(F)(F)F)cc2N(Cc2ccc(Cl)cc2)C1=O
InChIInChI=1S/C26H30ClF4N3O4S/c1-25(2,3)38-15-34(37)21-14-39-22-12-19(28)18(23(35)32-10-4-9-26(29,30)31)11-20(22)33(24(21)36)13-16-5-7-17(27)8-6-16/h5-8,11-12,21,34H,4,9-10,13-15H2,1-3H3,(H,32,35)/t21-/m0/s1
InChIKeyRTOMJNZIDTTXDQ-NRFANRHFSA-N
MW592.06 g/mol
LogP4.71
Rot. Bonds9

About (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide

(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide (PubChem CID 163944078) has the molecular formula C26H30ClF4N3O4S and a molecular weight of 592.06 g/mol. Its IUPAC name is (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide.

Molecular Properties

Compound Name(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide
PubChem CID163944078
Molecular FormulaC26H30ClF4N3O4S
Molecular Weight592.06 g/mol
Exact Mass591.16
IUPAC Name(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide
SMILESCC(C)(C)OC[NH+]([O-])[C@H]1CSc2cc(F)c(C(=O)NCCCC(F)(F)F)cc2N(Cc2ccc(Cl)cc2)C1=O
InChIInChI=1S/C26H30ClF4N3O4S/c1-25(2,3)38-15-34(37)21-14-39-22-12-19(28)18(23(35)32-10-4-9-26(29,30)31)11-20(22)33(24(21)36)13-16-5-7-17(27)8-6-16/h5-8,11-12,21,34H,4,9-10,13-15H2,1-3H3,(H,32,35)/t21-/m0/s1
InChIKeyRTOMJNZIDTTXDQ-NRFANRHFSA-N
XLogP4.71
TPSA86.14 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500592.06
LogP ≤ 54.71
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide?
The IUPAC name of (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide (CID 163944078) is (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide.
What is the SMILES notation for (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide?
The canonical SMILES for (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide is CC(C)(C)OC[NH+]([O-])[C@H]1CSc2cc(F)c(C(=O)NCCCC(F)(F)F)cc2N(Cc2ccc(Cl)cc2)C1=O.
What is the InChIKey of (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide?
The InChIKey is RTOMJNZIDTTXDQ-NRFANRHFSA-N. The full InChI is InChI=1S/C26H30ClF4N3O4S/c1-25(2,3)38-15-34(37)21-14-39-22-12-19(28)18(23(35)32-10-4-9-26(29,30)31)11-20(22)33(24(21)36)13-16-5-7-17(27)8-6-16/h5-8,11-12,21,34H,4,9-10,13-15H2,1-3H3,(H,32,35)/t21-/m0/s1.
What are the key properties of (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide?
(3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide has a molecular weight of 592.06 g/mol, XLogP of 4.71, 9 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-5-[(4-chlorophenyl)methyl]-8-fluoro-N-[(2-methylpropan-2-yl)oxymethyl]-4-oxo-7-(4,4,4-trifluorobutylcarbamoyl)-2,3-dihydro-1,5-benzothiazepin-3-amine oxide is sourced from PubChem (CID 163944078), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).